Pediatric Management of Crohn's Disease
Elana B Mitchel1, Joel R Rosh2
1Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Suite 7NW, Philadelphia, PA 19104, USA.
Insights
Pediatric Crohn's disease presents unique challenges, including severe symptoms and limited treatment options. Understanding these complexities is crucial for effective management in young patients.
Area of Science:
- Gastroenterology
- Pediatric Inflammatory Bowel Disease
Background:
- Pediatric Crohn's disease (PCD) exhibits greater severity and morbidity than adult-onset disease.
- PCD necessitates higher immunosuppression levels and presents unique challenges like growth impairment and pubertal delay.
Purpose of the Study:
- To highlight the distinct clinical considerations and treatment challenges in pediatric Crohn's disease.
- To emphasize the need for specialized knowledge among gastroenterologists managing pediatric IBD patients.
Main Methods:
- Review of existing literature on pediatric Crohn's disease management.
- Analysis of treatment options, evidence, and side effects for pediatric populations.
Main Results:
- Pediatric Crohn's disease is associated with significant morbidity, including growth and developmental issues.
- Limited therapeutic options often require off-label medication use in children.
Conclusions:
- Effective management of pediatric Crohn's disease requires a deep understanding of its unique aspects.
- Further research and evidence are needed to optimize treatment strategies for this vulnerable population.
Abstract:
Pediatric Crohn's disease is often more severe, requires higher levels of immunosuppression, and is associated with greater morbidity compared with adult Crohn's disease. Unique considerations in pediatric Crohn's disease include growth impairment, pubertal delay, bone disease, longevity of disease burden, and psychosocial impact. Treatment options are limited, requiring off-label use of therapy in this challenging patient population. Understanding the medications available, the existing evidence supporting their use, and side effects is important. There is tremendous potential for growth and improvement in this field and it is essential that all gastroenterologists have an understanding of this complex and unique patient population.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...


